<DOC>
	<DOC>NCT01218100</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of first-line treatment with a free combination (as two separate pills) of nebivolol and lisinopril in patients with stage 2 diastolic hypertension (DBP&gt;= 100 mmHg).</brief_summary>
	<brief_title>Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>male and female outpatients 18 to 64 years of age Females must be postmenopausal, or not pregnant and using an approved contraceptive regimen stage 2 diastolic hypertension (DBP &gt;= 100 mmHg) secondary hypertension evidence of other concurrent disease or conditions that might interfere with the conduct of the study participation in an investigational drug study within 30 days or 5 halflives, whichever is longer, of Screening (Visit 1). have a history of hypersensitivity to nebivolol or other βblockers, or any contraindication to βblocker use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>